Skip to main content

Articles

Serial Biopsies Identify Treatment Resistance and Inform Therapy Decisions in Patients with Advanced Solid Malignancies
Serial Biopsies Identify Treatment Resistance and Inform Therapy Decisions in Patients with Advanced Solid Malignancies
Biomarkers
Cancers often arise as a result of genomic instability and the evolution of neoplastic cell populations with variable types of genetic alterations.
Read More ›
Low-Grade Gliomas as a Model Malignancy for Preventing Oncogenic Signaling Through BRAF Inhibition
Low-Grade Gliomas as a Model Malignancy for Preventing Oncogenic Signaling Through BRAF Inhibition
Biomarkers
Low-grade glioma (LGG) represents the most frequently occurring central nervous system tumor among children, accounting for nearly one-third of all pediatric brain tumors.
Read More ›
Recent Advances in Therapeutic Targeting of NRG1 Fusion-Bearing Cancers
Recent Advances in Therapeutic Targeting of NRG1 Fusion-Bearing Cancers
Biomarkers
Oncogenic gene fusions are hybrid genes caused by DNA rearrangements, leading to the generation of protein products that can perturb key components of cellular activity, thus resulting in deregulated growth, proliferation, and differentiation.
Read More ›
Perspectives on Key Presentations in GI Cancer from ASCO-GI 2022: Part II
Perspectives on Key Presentations in GI Cancer from ASCO-GI 2022: Part II
Rapid Reactions

Read More ›
Perspectives on Key Presentations in GI Cancer from ASCO-GI 2022: Part I
Perspectives on Key Presentations in GI Cancer from ASCO-GI 2022: Part I
Rapid Reactions

Read More ›

Page 1 of 62